Citation Information :
Chaudhury A, Ramachandran P, Devaraj U, Maheswari U, D'Souza GA. Pleurodesis in Children with Povidone-Iodine: A New Intrapleural Drug. Indian J Chest Dis Allied Sci 2019; 61 (3):143-145.
Obliteration of pleural space by the adhesion of both the layers of pleura with chemical agents instilled intra-pleurally is termed as pleurodesis. Povidone-iodine is one of the newer agents used for pleurodesis in adults. We report a case of a successful povidone-iodine pleurodesis in a child who presented with recurrent pneumothorax.
Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 2003;88:F531–3.
Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. For the Euro Histio Network Pediatr Blood Cancer 2013;60:175–84. Published online 2012 Oct 25. doi: 10.1002/pbc.24367.
Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med 2009;15:380–7.
Noppen M, De Keukeleire T. Pneumothorax. Respiration 2008;76:121–7.
Echavarria A, Pinzon V, Bares JP, Fernandez E. Intracavitary treatment of malignant pleural effusion with iodine-povidone. Rev Med Panama 1991;16:69–74.
Estrada Salo G, Farina Rios C, FiblaAlfara JJ, Gomez Sebastian G, Unzueta MC, Leon Gonzalez C. Spontaneous pneumothorax: pleurodesis with an iodo-povidone hydroalcoholic solution. Arch Bronconeumol 2003;39:171–4.
Opitz I, Sigrist B, Hillinger S, Lardinois D, Stahel R, Weder W, et al. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma. Lung Cancer 2007;56:327–36.
Agarwal R. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis. Lung Cancer 2007;55:253–4.
Agarwal R, Khan A, Aggarwal A, Gupta D. Efficacy & safety of iodopovidone pleurodesis: a systematic review & meta-analysis. Indian J Med Res 2012:135:297–304.
Dey A, Bhuniya S, Datta Chaudhuri A, Pandit S, Saha-Dutta Chowdhury M, Sengupta A, et al. Iodopovidone pleurodesis: experience of a tertiary hospital in Kolkata. Singapore Med J 2010;51:163–5.
Kahrom H, Aghajanzadeh M, Asgari MR, Kahrom M. Efficacy and safety of povidone-iodine pleurodesis in malignant pleural effusions. Indian J Palliat Care 2017;23:53–56.
Resch B, Freidl T, Reiterer F. Povidone-iodine pleurodesis for congenital chylothorax of the newborn. Arch Dis Child Fetal Neonatal Ed 2016;101:F87–8.
Mitanchez D, Walter-Nicolet E, Salomon R, Bavoux F, Hubert P. Congenital chylothorax: what is the best strategy? Arch Dis Child Fetal Neonatal Ed 2006;91:F153–F156.
Scottoni F, Fusaro F, Conforti A, Morini F, Bagolan P. Pleurodesis with povidone–iodine for refractory chylothorax in newborns: personal experience and literature review. J Pediatr Surg 2015;50:1722–5.
Murki S, Faheemuddin M, Gaddam P. Congenital chylothorax: successful management with chemical pleurodesis. Indian J Pediatr 2010;77:332–4.
Abdul Aziz DA, Abdul Rahman NA, Tang SF, Abdul Latif H, Zaki FM, Annuar ZM, et al. Total pleurectomy as the surgical treatment for recurrent secondary spontaneous pneumothorax in a child with severe pulmonary Langerhans cells histiocytosis. BMJ Case Rep 2011;PMID:22674944.
Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 2006;11:105–8.
Agarwal R, Paul AS, Gupta D, Aggarwal AN, Jindal SK. A RCT on the efficacy of cosmetic talc vs. iodopovidone for chemical pleurodesis. Respirology 2011;16:1064–9.
Olivares-Torres CA, Laniado-Laborin R, Chavez-Garcia C, Leon-Gastelum C, Reyes-Escamilla A, Light RW. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002;122:581–3.
Wagenfeld L, Zeitz O, Richard G. Visual loss after povidoneiodine pleurodesis. N Engl J Med 2007;357:1264–5
